Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Degradable Implants was estimated to be worth US$ 4737 million in 2025 and is projected to reach US$ 7460 million, growing at a CAGR of 6.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Degradable Implants cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Degradable Implants Market Size(US$)
M= millions and B=billions

Degradable implants are innovative biomedical materials, mainly composed of natural or synthetic polymers, with good biocompatibility and biodegradability. After performing specific functions in the body for a period of time, these implants can degrade, disappear or be replaced by metabolites, without the need for secondary surgery to remove them. They not only relieve patients' pain, reduce the risk of secondary surgery and medical costs, but are also highly favored because their degradation products have no side effects on the human body. Degradable implants are widely used in orthopedics, cardiovascular and other fields, such as degradable magnesium alloy bone nails, zinc-based alloy vascular stents, etc., and have made important contributions to human health.
The North American market for Degradable Implants was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Degradable Implants was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Degradable Implants was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Degradable Implants market include Abbott Vascular, 3M, Royal DSM, Boston Scientific, Kyoto Medical Planning, Bakony Technical, Superior Technical Ceramics, LifeTech Scientific Corporation, SINOMED, Elixir, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Degradable Implants, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Degradable Implants market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Degradable Implants.
Market Segmentation
Report Metric
Details
Report Title
Degradable Implants- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 7460 million
CAGR(2026-2032)
6.8%
Market Size Available for Years
2026-2032
Global Degradable Implants Companies Covered
Abbott Vascular
3M
Royal DSM
Boston Scientific
Kyoto Medical Planning
Bakony Technical
Superior Technical Ceramics
LifeTech Scientific Corporation
SINOMED
Elixir
Arterial Remodeling Technologies
Japan Medical Device Technology
KYOCERA Corporation
Nobel Biocare Services
Morgan Advanced Materials
Tosoh Corporation
Institut Straumann
Elan Technology
Global Degradable Implants Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Degradable Implants Market, Segment by Type
Medical Composite Materials
Polymer Materials
Absorbable Metals
Absorbable Ceramics
Others
Global Degradable Implants Market, Segment by Application
Orthopedics
Cardiovascular
Dental
Neurosurgery
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Degradable Implants manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Degradable Implants sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Degradable Implants sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Degradable Implants Product Introduction
1.2 Global Degradable Implants Market Size Forecast
1.2.1 Global Degradable Implants Sales Value (2021–2032)
1.2.2 Global Degradable Implants Sales Volume (2021–2032)
1.2.3 Global Degradable Implants Sales Price (2021–2032)
1.3 Degradable Implants Market Trends & Drivers
1.3.1 Degradable Implants Industry Trends
1.3.2 Degradable Implants Market Drivers & Opportunities
1.3.3 Degradable Implants Market Challenges
1.3.4 Degradable Implants Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Degradable Implants Players Revenue Ranking (2025)
2.2 Global Degradable Implants Revenue by Company (2021–2026)
2.3 Global Degradable Implants Sales Volume Ranking of Players (2025)
2.4 Global Degradable Implants Sales Volume by Company (2021–2026)
2.5 Global Degradable Implants Average Price by Company (2021–2026)
2.6 Key Manufacturers Degradable Implants Manufacturing Base and Headquarters
2.7 Key Manufacturers Degradable Implants Product Offerings
2.8 Key Manufacturers Start of Mass Production of Degradable Implants
2.9 Degradable Implants Market Competitive Analysis
2.9.1 Degradable Implants Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Degradable Implants Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Degradable Implants revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Degradable Implants Market Classification
3.1 Introduction by Type
3.1.1 Medical Composite Materials
3.1.2 Polymer Materials
3.1.3 Absorbable Metals
3.1.4 Absorbable Ceramics
3.1.5 Others
3.1.6 Global Degradable Implants Sales Value by Type
3.1.6.1 Global Degradable Implants Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Degradable Implants Sales Value, by Type (2021–2032)
3.1.6.3 Global Degradable Implants Sales Value, by Type (%), 2021–2032
3.1.7 Global Degradable Implants Sales Volume by Type
3.1.7.1 Global Degradable Implants Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Degradable Implants Sales Volume, by Type (2021–2032)
3.1.7.3 Global Degradable Implants Sales Volume, by Type (%), 2021–2032
3.1.8 Global Degradable Implants Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Orthopedics
4.1.2 Cardiovascular
4.1.3 Dental
4.1.4 Neurosurgery
4.1.5 Others
4.2 Global Degradable Implants Sales Value by Application
4.2.1 Global Degradable Implants Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Degradable Implants Sales Value, by Application (2021–2032)
4.2.3 Global Degradable Implants Sales Value, by Application (%), 2021–2032
4.3 Global Degradable Implants Sales Volume by Application
4.3.1 Global Degradable Implants Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Degradable Implants Sales Volume, by Application (2021–2032)
4.3.3 Global Degradable Implants Sales Volume, by Application (%), 2021–2032
4.4 Global Degradable Implants Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Degradable Implants Sales Value by Region
5.1.1 Global Degradable Implants Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Degradable Implants Sales Value by Region (2021–2026)
5.1.3 Global Degradable Implants Sales Value by Region (2027–2032)
5.1.4 Global Degradable Implants Sales Value by Region (%), 2021–2032
5.2 Global Degradable Implants Sales Volume by Region
5.2.1 Global Degradable Implants Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Degradable Implants Sales Volume by Region (2021–2026)
5.2.3 Global Degradable Implants Sales Volume by Region (2027–2032)
5.2.4 Global Degradable Implants Sales Volume by Region (%), 2021–2032
5.3 Global Degradable Implants Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Degradable Implants Sales Value, 2021–2032
5.4.2 North America Degradable Implants Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Degradable Implants Sales Value, 2021–2032
5.5.2 Europe Degradable Implants Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Degradable Implants Sales Value, 2021–2032
5.6.2 Asia Pacific Degradable Implants Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Degradable Implants Sales Value, 2021–2032
5.7.2 South America Degradable Implants Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Degradable Implants Sales Value, 2021–2032
5.8.2 Middle East & Africa Degradable Implants Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Degradable Implants Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Degradable Implants Sales Value and Sales Volume
6.2.1 Key Countries/Regions Degradable Implants Sales Value, 2021–2032
6.2.2 Key Countries/Regions Degradable Implants Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Degradable Implants Sales Value, 2021–2032
6.3.2 United States Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Degradable Implants Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Degradable Implants Sales Value, 2021–2032
6.4.2 Europe Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Degradable Implants Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Degradable Implants Sales Value, 2021–2032
6.5.2 China Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.5.3 China Degradable Implants Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Degradable Implants Sales Value, 2021–2032
6.6.2 Japan Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Degradable Implants Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Degradable Implants Sales Value, 2021–2032
6.7.2 South Korea Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Degradable Implants Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Degradable Implants Sales Value, 2021–2032
6.8.2 Southeast Asia Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Degradable Implants Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Degradable Implants Sales Value, 2021–2032
6.9.2 India Degradable Implants Sales Value by Type (%), 2025 vs 2032
6.9.3 India Degradable Implants Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Abbott Vascular
7.1.1 Abbott Vascular Company Information
7.1.2 Abbott Vascular Introduction and Business Overview
7.1.3 Abbott Vascular Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Abbott Vascular Degradable Implants Product Offerings
7.1.5 Abbott Vascular Recent Developments
7.2 3M
7.2.1 3M Company Information
7.2.2 3M Introduction and Business Overview
7.2.3 3M Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 3M Degradable Implants Product Offerings
7.2.5 3M Recent Developments
7.3 Royal DSM
7.3.1 Royal DSM Company Information
7.3.2 Royal DSM Introduction and Business Overview
7.3.3 Royal DSM Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Royal DSM Degradable Implants Product Offerings
7.3.5 Royal DSM Recent Developments
7.4 Boston Scientific
7.4.1 Boston Scientific Company Information
7.4.2 Boston Scientific Introduction and Business Overview
7.4.3 Boston Scientific Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Boston Scientific Degradable Implants Product Offerings
7.4.5 Boston Scientific Recent Developments
7.5 Kyoto Medical Planning
7.5.1 Kyoto Medical Planning Company Information
7.5.2 Kyoto Medical Planning Introduction and Business Overview
7.5.3 Kyoto Medical Planning Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Kyoto Medical Planning Degradable Implants Product Offerings
7.5.5 Kyoto Medical Planning Recent Developments
7.6 Bakony Technical
7.6.1 Bakony Technical Company Information
7.6.2 Bakony Technical Introduction and Business Overview
7.6.3 Bakony Technical Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Bakony Technical Degradable Implants Product Offerings
7.6.5 Bakony Technical Recent Developments
7.7 Superior Technical Ceramics
7.7.1 Superior Technical Ceramics Company Information
7.7.2 Superior Technical Ceramics Introduction and Business Overview
7.7.3 Superior Technical Ceramics Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Superior Technical Ceramics Degradable Implants Product Offerings
7.7.5 Superior Technical Ceramics Recent Developments
7.8 LifeTech Scientific Corporation
7.8.1 LifeTech Scientific Corporation Company Information
7.8.2 LifeTech Scientific Corporation Introduction and Business Overview
7.8.3 LifeTech Scientific Corporation Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 LifeTech Scientific Corporation Degradable Implants Product Offerings
7.8.5 LifeTech Scientific Corporation Recent Developments
7.9 SINOMED
7.9.1 SINOMED Company Information
7.9.2 SINOMED Introduction and Business Overview
7.9.3 SINOMED Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 SINOMED Degradable Implants Product Offerings
7.9.5 SINOMED Recent Developments
7.10 Elixir
7.10.1 Elixir Company Information
7.10.2 Elixir Introduction and Business Overview
7.10.3 Elixir Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Elixir Degradable Implants Product Offerings
7.10.5 Elixir Recent Developments
7.11 Arterial Remodeling Technologies
7.11.1 Arterial Remodeling Technologies Company Information
7.11.2 Arterial Remodeling Technologies Introduction and Business Overview
7.11.3 Arterial Remodeling Technologies Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Arterial Remodeling Technologies Degradable Implants Product Offerings
7.11.5 Arterial Remodeling Technologies Recent Developments
7.12 Japan Medical Device Technology
7.12.1 Japan Medical Device Technology Company Information
7.12.2 Japan Medical Device Technology Introduction and Business Overview
7.12.3 Japan Medical Device Technology Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Japan Medical Device Technology Degradable Implants Product Offerings
7.12.5 Japan Medical Device Technology Recent Developments
7.13 KYOCERA Corporation
7.13.1 KYOCERA Corporation Company Information
7.13.2 KYOCERA Corporation Introduction and Business Overview
7.13.3 KYOCERA Corporation Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 KYOCERA Corporation Degradable Implants Product Offerings
7.13.5 KYOCERA Corporation Recent Developments
7.14 Nobel Biocare Services
7.14.1 Nobel Biocare Services Company Information
7.14.2 Nobel Biocare Services Introduction and Business Overview
7.14.3 Nobel Biocare Services Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Nobel Biocare Services Degradable Implants Product Offerings
7.14.5 Nobel Biocare Services Recent Developments
7.15 Morgan Advanced Materials
7.15.1 Morgan Advanced Materials Company Information
7.15.2 Morgan Advanced Materials Introduction and Business Overview
7.15.3 Morgan Advanced Materials Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Morgan Advanced Materials Degradable Implants Product Offerings
7.15.5 Morgan Advanced Materials Recent Developments
7.16 Tosoh Corporation
7.16.1 Tosoh Corporation Company Information
7.16.2 Tosoh Corporation Introduction and Business Overview
7.16.3 Tosoh Corporation Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Tosoh Corporation Degradable Implants Product Offerings
7.16.5 Tosoh Corporation Recent Developments
7.17 Institut Straumann
7.17.1 Institut Straumann Company Information
7.17.2 Institut Straumann Introduction and Business Overview
7.17.3 Institut Straumann Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Institut Straumann Degradable Implants Product Offerings
7.17.5 Institut Straumann Recent Developments
7.18 Elan Technology
7.18.1 Elan Technology Company Information
7.18.2 Elan Technology Introduction and Business Overview
7.18.3 Elan Technology Degradable Implants Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Elan Technology Degradable Implants Product Offerings
7.18.5 Elan Technology Recent Developments
8 Industry Chain Analysis
8.1 Degradable Implants Industrial Chain
8.2 Degradable Implants Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Degradable Implants Sales Model
8.5.2 Sales Channels
8.5.3 Degradable Implants Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Degradable Implants Market Trends
Table 2. Degradable Implants Market Drivers & Opportunities
Table 3. Degradable Implants Market Challenges
Table 4. Degradable Implants Market Restraints
Table 5. Global Degradable Implants Revenue by Company (US$ Million), 2021–2026
Table 6. Global Degradable Implants Revenue Market Share by Company (2021–2026)
Table 7. Global Degradable Implants Sales Volume by Company (K Units), 2021–2026
Table 8. Global Degradable Implants Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Degradable Implants Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Degradable Implants Manufacturing Base and Headquarters
Table 11. Key Manufacturers Degradable Implants Product Type
Table 12. Key Manufacturers Start of Mass Production of Degradable Implants
Table 13. Global Degradable Implants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Degradable Implants revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Degradable Implants Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Degradable Implants Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Degradable Implants Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Degradable Implants Sales Market Share in Value by Type (2021–2026)
Table 20. Global Degradable Implants Sales Market Share in Value by Type (2027–2032)
Table 21. Global Degradable Implants Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Degradable Implants Sales Volume by Type (K Units), 2021–2026
Table 23. Global Degradable Implants Sales Volume by Type (K Units), 2027–2032
Table 24. Global Degradable Implants Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Degradable Implants Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Degradable Implants Price by Type (US$/Unit), 2021–2026
Table 27. Global Degradable Implants Price by Type (US$/Unit), 2027–2032
Table 28. Global Degradable Implants Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Degradable Implants Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Degradable Implants Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Degradable Implants Sales Market Share in Value by Application (2021–2026)
Table 32. Global Degradable Implants Sales Market Share in Value by Application (2027–2032)
Table 33. Global Degradable Implants Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Degradable Implants Sales Volume by Application (K Units), 2021–2026
Table 35. Global Degradable Implants Sales Volume by Application (K Units), 2027–2032
Table 36. Global Degradable Implants Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Degradable Implants Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Degradable Implants Price by Application (US$/Unit), 2021–2026
Table 39. Global Degradable Implants Price by Application (US$/Unit), 2027–2032
Table 40. Global Degradable Implants Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Degradable Implants Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Degradable Implants Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Degradable Implants Sales Value by Region (%), 2021–2026
Table 44. Global Degradable Implants Sales Value by Region (%), 2027–2032
Table 45. Global Degradable Implants Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Degradable Implants Sales Volume by Region (K Units), 2021–2026
Table 47. Global Degradable Implants Sales Volume by Region (K Units), 2027–2032
Table 48. Global Degradable Implants Sales Volume by Region (%), 2021–2026
Table 49. Global Degradable Implants Sales Volume by Region (%), 2027–2032
Table 50. Global Degradable Implants Average Price by Region (US$/Unit), 2021–2026
Table 51. Global Degradable Implants Average Price by Region (US$/Unit), 2027–2032
Table 52. Key Countries/Regions Degradable Implants Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Degradable Implants Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Degradable Implants Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Degradable Implants Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Degradable Implants Sales Volume, (K Units), 2027–2032
Table 57. Abbott Vascular Company Information
Table 58. Abbott Vascular Introduction and Business Overview
Table 59. Abbott Vascular Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 60. Abbott Vascular Degradable Implants Product Offerings
Table 61. Abbott Vascular Recent Developments
Table 62. 3M Company Information
Table 63. 3M Introduction and Business Overview
Table 64. 3M Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 65. 3M Degradable Implants Product Offerings
Table 66. 3M Recent Developments
Table 67. Royal DSM Company Information
Table 68. Royal DSM Introduction and Business Overview
Table 69. Royal DSM Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 70. Royal DSM Degradable Implants Product Offerings
Table 71. Royal DSM Recent Developments
Table 72. Boston Scientific Company Information
Table 73. Boston Scientific Introduction and Business Overview
Table 74. Boston Scientific Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 75. Boston Scientific Degradable Implants Product Offerings
Table 76. Boston Scientific Recent Developments
Table 77. Kyoto Medical Planning Company Information
Table 78. Kyoto Medical Planning Introduction and Business Overview
Table 79. Kyoto Medical Planning Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 80. Kyoto Medical Planning Degradable Implants Product Offerings
Table 81. Kyoto Medical Planning Recent Developments
Table 82. Bakony Technical Company Information
Table 83. Bakony Technical Introduction and Business Overview
Table 84. Bakony Technical Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 85. Bakony Technical Degradable Implants Product Offerings
Table 86. Bakony Technical Recent Developments
Table 87. Superior Technical Ceramics Company Information
Table 88. Superior Technical Ceramics Introduction and Business Overview
Table 89. Superior Technical Ceramics Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 90. Superior Technical Ceramics Degradable Implants Product Offerings
Table 91. Superior Technical Ceramics Recent Developments
Table 92. LifeTech Scientific Corporation Company Information
Table 93. LifeTech Scientific Corporation Introduction and Business Overview
Table 94. LifeTech Scientific Corporation Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 95. LifeTech Scientific Corporation Degradable Implants Product Offerings
Table 96. LifeTech Scientific Corporation Recent Developments
Table 97. SINOMED Company Information
Table 98. SINOMED Introduction and Business Overview
Table 99. SINOMED Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 100. SINOMED Degradable Implants Product Offerings
Table 101. SINOMED Recent Developments
Table 102. Elixir Company Information
Table 103. Elixir Introduction and Business Overview
Table 104. Elixir Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 105. Elixir Degradable Implants Product Offerings
Table 106. Elixir Recent Developments
Table 107. Arterial Remodeling Technologies Company Information
Table 108. Arterial Remodeling Technologies Introduction and Business Overview
Table 109. Arterial Remodeling Technologies Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 110. Arterial Remodeling Technologies Degradable Implants Product Offerings
Table 111. Arterial Remodeling Technologies Recent Developments
Table 112. Japan Medical Device Technology Company Information
Table 113. Japan Medical Device Technology Introduction and Business Overview
Table 114. Japan Medical Device Technology Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 115. Japan Medical Device Technology Degradable Implants Product Offerings
Table 116. Japan Medical Device Technology Recent Developments
Table 117. KYOCERA Corporation Company Information
Table 118. KYOCERA Corporation Introduction and Business Overview
Table 119. KYOCERA Corporation Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 120. KYOCERA Corporation Degradable Implants Product Offerings
Table 121. KYOCERA Corporation Recent Developments
Table 122. Nobel Biocare Services Company Information
Table 123. Nobel Biocare Services Introduction and Business Overview
Table 124. Nobel Biocare Services Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 125. Nobel Biocare Services Degradable Implants Product Offerings
Table 126. Nobel Biocare Services Recent Developments
Table 127. Morgan Advanced Materials Company Information
Table 128. Morgan Advanced Materials Introduction and Business Overview
Table 129. Morgan Advanced Materials Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 130. Morgan Advanced Materials Degradable Implants Product Offerings
Table 131. Morgan Advanced Materials Recent Developments
Table 132. Tosoh Corporation Company Information
Table 133. Tosoh Corporation Introduction and Business Overview
Table 134. Tosoh Corporation Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 135. Tosoh Corporation Degradable Implants Product Offerings
Table 136. Tosoh Corporation Recent Developments
Table 137. Institut Straumann Company Information
Table 138. Institut Straumann Introduction and Business Overview
Table 139. Institut Straumann Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 140. Institut Straumann Degradable Implants Product Offerings
Table 141. Institut Straumann Recent Developments
Table 142. Elan Technology Company Information
Table 143. Elan Technology Introduction and Business Overview
Table 144. Elan Technology Degradable Implants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 145. Elan Technology Degradable Implants Product Offerings
Table 146. Elan Technology Recent Developments
Table 147. Key Raw Materials Lists
Table 148. Key Suppliers of Raw Materials Lists
Table 149. Degradable Implants Downstream Customers
Table 150. Degradable Implants Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Degradable Implants Product Picture
Figure 2. Global Degradable Implants Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 4. Global Degradable Implants Sales Volume (K Units), 2021–2032
Figure 5. Global Degradable Implants Sales Price (US$/Unit), 2021–2032
Figure 6. Degradable Implants Report Years Considered
Figure 7. Global Degradable Implants Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Degradable Implants Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Degradable Implants Revenue in 2025
Figure 10. Degradable Implants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Medical Composite Materials Picture
Figure 12. Polymer Materials Picture
Figure 13. Absorbable Metals Picture
Figure 14. Absorbable Ceramics Picture
Figure 15. Others Picture
Figure 16. Global Degradable Implants Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Degradable Implants Sales Value Market Share by Type, 2025 & 2032
Figure 18. Global Degradable Implants Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 19. Global Degradable Implants Sales Volume Market Share by Type, 2025 & 2032
Figure 20. Global Degradable Implants Price by Type (US$/Unit), 2021–2032
Figure 21. Product Picture of Orthopedics
Figure 22. Product Picture of Cardiovascular
Figure 23. Product Picture of Dental
Figure 24. Product Picture of Neurosurgery
Figure 25. Product Picture of Others
Figure 26. Global Degradable Implants Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Degradable Implants Sales Value Market Share by Application, 2025 & 2032
Figure 28. Global Degradable Implants Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 29. Global Degradable Implants Sales Volume Market Share by Application, 2025 & 2032
Figure 30. Global Degradable Implants Price by Application (US$/Unit), 2021–2032
Figure 31. North America Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 32. North America Degradable Implants Sales Value by Country (%), 2025 vs 2032
Figure 33. Europe Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 34. Europe Degradable Implants Sales Value by Country (%), 2025 vs 2032
Figure 35. Asia Pacific Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 36. Asia Pacific Degradable Implants Sales Value by Region (%), 2025 vs 2032
Figure 37. South America Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 38. South America Degradable Implants Sales Value by Country (%), 2025 vs 2032
Figure 39. Middle East & Africa Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 40. Middle East & Africa Degradable Implants Sales Value by Country (%), 2025 vs 2032
Figure 41. Key Countries/Regions Degradable Implants Sales Value (%), 2021–2032
Figure 42. Key Countries/Regions Degradable Implants Sales Volume (%), 2021–2032
Figure 43. United States Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 44. United States Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 45. United States Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 46. Europe Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 47. Europe Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 48. Europe Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 49. China Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 50. China Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 51. China Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 52. Japan Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 53. Japan Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 54. Japan Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 55. South Korea Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 56. South Korea Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 57. South Korea Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 58. Southeast Asia Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 59. Southeast Asia Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 60. Southeast Asia Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 61. India Degradable Implants Sales Value (US$ Million), 2021–2032
Figure 62. India Degradable Implants Sales Value by Type (%), 2025 vs 2032
Figure 63. India Degradable Implants Sales Value by Application (%), 2025 vs 2032
Figure 64. Degradable Implants Industrial Chain
Figure 65. Degradable Implants Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives InterviewedDescription
The global market for Degradable Implants was estimated to be worth US$ 4737 million in 2025 and is projected to reach US$ 7460 million, growing at a CAGR of 6.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Degradable Implants cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Degradable implants are innovative biomedical materials, mainly composed of natural or synthetic polymers, with good biocompatibility and biodegradability. After performing specific functions in the body for a period of time, these implants can degrade, disappear or be replaced by metabolites, without the need for secondary surgery to remove them. They not only relieve patients' pain, reduce the risk of secondary surgery and medical costs, but are also highly favored because their degradation products have no side effects on the human body. Degradable implants are widely used in orthopedics, cardiovascular and other fields, such as degradable magnesium alloy bone nails, zinc-based alloy vascular stents, etc., and have made important contributions to human health.
The North American market for Degradable Implants was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Degradable Implants was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Degradable Implants was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Degradable Implants market include Abbott Vascular, 3M, Royal DSM, Boston Scientific, Kyoto Medical Planning, Bakony Technical, Superior Technical Ceramics, LifeTech Scientific Corporation, SINOMED, Elixir, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Degradable Implants, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Degradable Implants market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Degradable Implants.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Degradable Implants manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Degradable Implants sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Degradable Implants sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Related Reports
The global market for Degradable Implants was valued at US$ 4436 million in the year 2024 and is projected to reach a revised size of US$ 7030 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-04-09
Pages: 101
USD 2900.00
(Single User License)
The global Degradable Implants market is projected to grow from US$ 4737 million in 2025 to US$ 7030 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2025-04-09
Pages: 180
USD 4900.00
(Single User License)
The global market for Degradable Implants was estimated to be worth US$ 4436 million in 2024 and is forecast to a readjusted size of US$ 7030 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-04-09
Pages: 146
USD 3950.00
(Single User License)
The global Degradable Implants market size was US$ 4436 million in 2024 and is forecast to a readjusted size of US$ 7030 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-04-09
Pages: 102
USD 4250.00
(Single User License)
The global Degradable Implants market size was US$ 4737 million in 2025 and is forecast to reach a readjusted size of US$ 7460 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 102
USD 4250.00
(Single User License)
The global Degradable Implants market was valued at US$ 4737 million in 2025 and is anticipated to reach US$ 7460 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 129
USD 2900.00
(Single User License)
The global Degradable Implants market is projected to grow from US$ 4737 million in 2025 to US$ 7460 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 171
USD 4900.00
(Single User License)
The global market for Degradable Implants was valued at US$ 4436 million in the year 2024 and is projected to reach a revised size of US$ 7030 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-04-09
Pages: 101
The global Degradable Implants market is projected to grow from US$ 4737 million in 2025 to US$ 7030 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.8% during the forecast period.
Published: 2025-04-09
Pages: 180
The global market for Degradable Implants was estimated to be worth US$ 4436 million in 2024 and is forecast to a readjusted size of US$ 7030 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-04-09
Pages: 146
The global Degradable Implants market size was US$ 4436 million in 2024 and is forecast to a readjusted size of US$ 7030 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-04-09
Pages: 102
The global Degradable Implants market size was US$ 4737 million in 2025 and is forecast to reach a readjusted size of US$ 7460 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 102
The global Degradable Implants market was valued at US$ 4737 million in 2025 and is anticipated to reach US$ 7460 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-03-11
Pages: 129
The global Degradable Implants market is projected to grow from US$ 4737 million in 2025 to US$ 7460 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 171
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database